Logo image of IES.DE

INTESA SANPAOLO (IES.DE) Stock Fundamental Analysis

FRA:IES - Deutsche Boerse Ag - IT0000072618 - Common Stock - Currency: EUR

4.8895  +0.02 (+0.48%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to IES. IES was compared to 99 industry peers in the Banks industry. While IES is still in line with the averages on profitability rating, there are concerns on its financial health. IES is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year IES was profitable.
IES had positive earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: IES reported negative operating cash flow in multiple years.
IES.DE Yearly Net Income VS EBIT VS OCF VS FCFIES.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B 40B 60B 80B 100B

1.2 Ratios

IES has a better Return On Assets (1.44%) than 88.89% of its industry peers.
The Return On Equity of IES (20.61%) is better than 93.94% of its industry peers.
Industry RankSector Rank
ROA 1.44%
ROE 20.61%
ROIC N/A
ROA(3y)0.73%
ROA(5y)0.58%
ROE(3y)10.85%
ROE(5y)8.82%
ROIC(3y)N/A
ROIC(5y)N/A
IES.DE Yearly ROA, ROE, ROICIES.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

Looking at the Profit Margin, with a value of 27.57%, IES is in the better half of the industry, outperforming 72.73% of the companies in the same industry.
IES's Profit Margin has improved in the last couple of years.
The Operating Margin and Gross Margin are not available for IES so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 27.57%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y41.94%
PM growth 5Y20.69%
GM growth 3YN/A
GM growth 5YN/A
IES.DE Yearly Profit, Operating, Gross MarginsIES.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1

2. Health

2.1 Basic Checks

IES does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, IES has more shares outstanding
Compared to 5 years ago, IES has more shares outstanding
Compared to 1 year ago, IES has an improved debt to assets ratio.
IES.DE Yearly Shares OutstandingIES.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B
IES.DE Yearly Total Debt VS Total AssetsIES.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200B 400B 600B 800B 1T

2.2 Solvency

IES has a Debt/Equity ratio of 0.69. This is a neutral value indicating IES is somewhat dependend on debt financing.
IES has a better Debt to Equity ratio (0.69) than 83.84% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.69
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC5.34%
IES.DE Yearly LT Debt VS Equity VS FCFIES.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50B 100B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
IES.DE Yearly Current Assets VS Current LiabilitesIES.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B

3

3. Growth

3.1 Past

IES shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 19.90%, which is quite good.
The Earnings Per Share has been growing by 14.39% on average over the past years. This is quite good.
IES shows a strong growth in Revenue. In the last year, the Revenue has grown by 26.05%.
Measured over the past years, IES shows a decrease in Revenue. The Revenue has been decreasing by -4.15% on average per year.
EPS 1Y (TTM)19.9%
EPS 3Y28.79%
EPS 5Y14.39%
EPS Q2Q%-2.44%
Revenue 1Y (TTM)26.05%
Revenue growth 3Y-10.2%
Revenue growth 5Y-4.15%
Sales Q2Q%4.63%

3.2 Future

The Earnings Per Share is expected to decrease by -1.66% on average over the next years.
Based on estimates for the next years, IES will show a decrease in Revenue. The Revenue will decrease by 0.00% on average per year.
EPS Next Y11.91%
EPS Next 2Y7.53%
EPS Next 3Y6.49%
EPS Next 5Y-1.66%
Revenue Next Year-0.23%
Revenue Next 2Y0.27%
Revenue Next 3Y0.8%
Revenue Next 5Y0%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
IES.DE Yearly Revenue VS EstimatesIES.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 10B 20B 30B 40B
IES.DE Yearly EPS VS EstimatesIES.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.1 0.2 0.3 0.4 0.5

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 10.40, which indicates a very decent valuation of IES.
Based on the Price/Earnings ratio, IES is valued a bit more expensive than 62.63% of the companies in the same industry.
IES is valuated cheaply when we compare the Price/Earnings ratio to 29.35, which is the current average of the S&P500 Index.
IES is valuated reasonably with a Price/Forward Earnings ratio of 9.30.
Compared to the rest of the industry, the Price/Forward Earnings ratio of IES indicates a somewhat cheap valuation: IES is cheaper than 60.61% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of IES to the average of the S&P500 Index (22.10), we can say IES is valued rather cheaply.
Industry RankSector Rank
PE 10.4
Fwd PE 9.3
IES.DE Price Earnings VS Forward Price EarningsIES.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
IES.DE Per share dataIES.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.87
PEG (5Y)0.72
EPS Next 2Y7.53%
EPS Next 3Y6.49%

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 7.01%, IES is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 5.06, IES pays a better dividend. On top of this IES pays more dividend than 85.86% of the companies listed in the same industry.
IES's Dividend Yield is rather good when compared to the S&P500 average which is at 2.33.
Industry RankSector Rank
Dividend Yield 7.01%

5.2 History

The dividend of IES has a limited annual growth rate of 3.16%.
Dividend Growth(5Y)3.16%
Div Incr Years2
Div Non Decr Years2
IES.DE Yearly Dividends per shareIES.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.1 0.2 0.3

5.3 Sustainability

DP0%
EPS Next 2Y7.53%
EPS Next 3Y6.49%
IES.DE Yearly Income VS Free CF VS DividendIES.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B 40B 60B 80B 100B

INTESA SANPAOLO

FRA:IES (3/7/2025, 7:00:00 PM)

4.8895

+0.02 (+0.48%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)02-04 2025-02-04/dmh
Earnings (Next)05-06 2025-05-06
Inst Owners34.48%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap87.05B
Analysts80.71
Price Target4.88 (-0.19%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 7.01%
Yearly Dividend0.24
Dividend Growth(5Y)3.16%
DP0%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-5.9%
Min EPS beat(2)-12.96%
Max EPS beat(2)1.15%
EPS beat(4)2
Avg EPS beat(4)-0.39%
Min EPS beat(4)-12.96%
Max EPS beat(4)11.44%
EPS beat(8)4
Avg EPS beat(8)0.65%
EPS beat(12)8
Avg EPS beat(12)11.11%
EPS beat(16)12
Avg EPS beat(16)28.59%
Revenue beat(2)2
Avg Revenue beat(2)1.88%
Min Revenue beat(2)1.54%
Max Revenue beat(2)2.22%
Revenue beat(4)3
Avg Revenue beat(4)1.49%
Min Revenue beat(4)-0.35%
Max Revenue beat(4)2.53%
Revenue beat(8)6
Avg Revenue beat(8)16.33%
Revenue beat(12)9
Avg Revenue beat(12)21.31%
Revenue beat(16)13
Avg Revenue beat(16)37.85%
PT rev (1m)4.77%
PT rev (3m)9.23%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.46%
EPS NY rev (3m)3.98%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.46%
Revenue NY rev (3m)1.23%
Valuation
Industry RankSector Rank
PE 10.4
Fwd PE 9.3
P/S 1.79
P/FCF N/A
P/OCF N/A
P/B 1.34
P/tB 1.34
EV/EBITDA N/A
EPS(TTM)0.47
EY9.61%
EPS(NY)0.53
Fwd EY10.76%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS2.74
BVpS3.66
TBVpS3.66
PEG (NY)0.87
PEG (5Y)0.72
Profitability
Industry RankSector Rank
ROA 1.44%
ROE 20.61%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 27.57%
GM N/A
FCFM N/A
ROA(3y)0.73%
ROA(5y)0.58%
ROE(3y)10.85%
ROE(5y)8.82%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y41.94%
PM growth 5Y20.69%
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 0.69
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-ScoreN/A
WACC5.34%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)19.9%
EPS 3Y28.79%
EPS 5Y14.39%
EPS Q2Q%-2.44%
EPS Next Y11.91%
EPS Next 2Y7.53%
EPS Next 3Y6.49%
EPS Next 5Y-1.66%
Revenue 1Y (TTM)26.05%
Revenue growth 3Y-10.2%
Revenue growth 5Y-4.15%
Sales Q2Q%4.63%
Revenue Next Year-0.23%
Revenue Next 2Y0.27%
Revenue Next 3Y0.8%
Revenue Next 5Y0%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A